SYN-101094R1

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSYN-101094R1
Drug Alias NameSYN-101094R1
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperlipidemiasLipid Metabolism Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSynmosa Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSynmosa Biopharma Corp
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasLipid Metabolism Disorders

Other Information

ATC CodeN/A
Related LinksN/A